Alveus Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Alveus Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D (NCT07399678) | Alveus Therapeutics, Inc. | 2025-12-29 |
Track Alveus Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.